THE EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS

Figures converted to GBP from EUR at 0.856 per EUR (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. THE EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS 1996-11-27 → present
2. THE EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS LIMITED 1996-02-01 → 1996-11-27

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Crowe U.K. LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“On this basis the Directors are confident that the group will continue in operational existence and that the financial statements should continue to be drawn up on a going concern basis.”

Group structure

1. THE EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS · parent
   1. ESCRS Trading Limited 100% · United Kingdom · arranging and hosting the annual meetings of ESCRS and publishing the society's magazine, EuroTimes.

Significant events

• “The 28th ESCRS Winter Meeting took place in Frankfurt, Germany as an in-person event in February 2024 and was attended by over 1,500 delegates.”
• “The society held the 42nd Annual Congress of ESCRS as a hybrid (in-person and virtual) meeting in Barcelona in September 2024. The meeting was an enormous success and retained its position reached in 2022, as the largest ophthalmic conference in the world concerning visiting doctors. A total of over 15,900 delegates attended.”
• “In 2024, the society launched its programme focused on Building our Sustainable Society (BoSS), which addresses sustainability in a wider sense, incorporating diversity and inclusion.”
• “The third ESCRS iNovation Day, a one-day meeting which brings together clinical and business experts from across Europe and further afield, was held immediately before the Annual Congress in Barcelona.”
• “Three new Systematic Research Awards were made in 2024.”
• “One new Pioneer Award was agreed for VICTORIA (Validation of Interleukins and other Cytokines Together with OCT imaging for Rapid Infectious keratitis Assessment).”
• “The Research Committee also established a new award in 2024, the Sustainability Research Award (SURE Award), with a maximum value of €10,000 per award.”
• “ESCRS makes direct donations each year to selected charities. 2024 was the second year of three major projects funded by ESCRS which run from 2023 to 2025.”
• “A new project with the Cape Town University Eye Health Institute (CEHI) was launched in 2024, receiving €90k of funding over 12 months.”
• “The society has also designated a total of €150k from its own reserves for the same purpose, of which €92k remains available to spend.”
• “Following a tender process, Cazenove was appointed as the society's investment manager in March 2024. The transfer of assets from the previous investment managers to Cazenove was completed during the year.”
• “in early 2024 agreed an extension to the agreement with its outsourced services provider which provides certainty over ongoing fixed costs for several years.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.